Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system

Yingying Hu; Jian Gong; Lifu Zhang; Xiaolin Li; Xina Li; Bin Zhao; Xin Hai

doi:10.1016/j.intimp.2020.106601

Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system

著者: Yingying Hu, Jian Gong, Lifu Zhang, Xiaolin Li, Xina Li, Bin Zhao, Xin Hai - International Immunopharmacology 2020 被引用: 96

Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system | Litlas